ArrowMark Colorado Holdings’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,812,710
Closed -$61.6M 376
2021
Q3
$61.6M Buy
1,812,710
+259,427
+17% +$8.28M 0.48% 63
2021
Q2
$56.9M Sell
1,553,283
-57,400
-4% -$2.22M 0.43% 73
2021
Q1
$72.2M Buy
1,610,683
+60,183
+4% +$2.8M 0.54% 57
2020
Q4
$88.5M Buy
1,550,500
+10,282
+0.7% +$609K 0.69% 53
2020
Q3
$79M Sell
1,540,218
-28,451
-2% -$1.39M 0.75% 44
2020
Q2
$93.7M Sell
1,568,669
-115,925
-7% -$6.2M 0.97% 31
2020
Q1
$69.4M Sell
1,684,594
-8,662
-0.5% -$481K 0.91% 38
2019
Q4
$105M Sell
1,693,256
-66,594
-4% -$3.17M 0.94% 39
2019
Q3
$59.7M Buy
1,759,850
+1,215,553
+223% +$36M 0.6% 59
2019
Q2
$12.3M Buy
544,297
+150,365
+38% +$3.52M 0.12% 148
2019
Q1
$9.14M Buy
393,932
+37,975
+11% +$994K 0.09% 177
2018
Q4
$7.47M Buy
355,957
+24,967
+8% +$614K 0.08% 198
2018
Q3
$12.8M Buy
330,990
+16,593
+5% +$613K 0.11% 173
2018
Q2
$12.4M Buy
+314,397
New +$9.25M 0.11% 172
2018
Q1
Sell
-231,760
Closed -$5.25M 348
2017
Q4
$5.25M Buy
231,760
+30,475
+15% +$597K 0.05% 216
2017
Q3
$3.82M Buy
+201,285
New +$3.69M 0.04% 232

Other funds holding DCPH

ArrowMark Colorado Holdings's DCPH Position: Q4 2021 in Review

ArrowMark Colorado Holdings sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 1,812,710 shares — an estimated $61.6M sold.

ArrowMark Colorado Holdings first reported a position in DCPH in Q3 2017 and held it in 16 quarters. The position peaked at $105M in Q4 2019. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

  • ArrowMark Colorado Holdings reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 1,812,710 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $61.6M.
  • ArrowMark Colorado Holdings first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 16 quarters.
  • ArrowMark Colorado Holdings's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $105M in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.